TITLE

Treatment of an atazanivir associated grade 4 hyperbilirubinaemia with efavirenz

AUTHOR(S)
Kummer, O.; Mossdorf, M.; Battegay, M.; Elzi, L.; Bodmer, M.; Krähenbühl, S.; Haschke, M.
PUB. DATE
October 2007
SOURCE
Gut;Oct2007, Vol. 56 Issue 10, p1477
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
A letter to the editor is presented in response to the article about treatment of an atazanivir associated grade 4 hyperbilirubinaemia with efavirenz, which appeared in the previous issue.
ACCESSION #
27148491

 

Related Articles

  • Use of antiretrovirals in newborns. Robinson, Joan L. // CMAJ: Canadian Medical Association Journal;10/28/2003, Vol. 169 Issue 9, p901 

    Presents a letter to the editor about the use of antiretrovirals in newborns.

  • [Five of the authors respond:]. Burdge, David R.; Money, Deborah M.; Forbes, John C.; Samson, Lindy M.; Walmsley, Sharon L. // CMAJ: Canadian Medical Association Journal;10/28/2003, Vol. 169 Issue 9, p901 

    Presents a response to a letter to the editor about the use of antiretrovirals in newborns.

  • Tenofovir DF and Emtricitabine vs. Zidovudine and Lamivudine. Laessig, Katherine A.; Lewis, Linda L.; Hammerstrom, Thomas S. // New England Journal of Medicine;6/8/2006, Vol. 354 Issue 23, p2506 

    A letter to the editor is presented in response to the article "Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIV," by J. E. Gallant, E. DeJesus, J. R. Arribas et al. in the January 19, 2006 issue.

  • Tenofovir DF and Emtricitabine vs. Zidovudine and Lamivudine. Jenny-Avital, Elizabeth R. // New England Journal of Medicine;6/8/2006, Vol. 354 Issue 23, p2506 

    A letter to the editor is presented in response to the article "Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIV," by J. E. Gallant, E. DeJesus, J. R. Arribas et al. in the January 19, 2006 issue.

  • Tenofovir DF and Emtricitabine vs. Zidovudine and Lamivudine. Gallant, Joel E.; DeJesus, Edwin; Cheng, Andrew K. // New England Journal of Medicine;6/8/2006, Vol. 354 Issue 23, p2506 

    A response by J. E. Gallant, E. DeJesus, J. R. Arribas et al. to letters to the editor about their article "Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIV," in the January 19, 2006 issue is presented.

  • Augmented effect of five percent imiquimod cream and antiretroviral therapy in resolution of giant molluscum contagiosum. Choudhary, Sanjiv V.; Singh, Adarshlata; Gupta, Sumit; Koley, Sankha // Indian Journal of Sexually Transmitted Diseases;2008, Vol. 29 Issue 2, p102 

    A letter to the editor is presented on the augmented effect of five percent imiquimod cream and antiretroviral therapy in resolution of giant molluscum contagiosum.

  • Treating HIV Encephalopathy with Antiretroviral Therapy: A Clinical Case Demonstrating the Success of HAART. Shah, P.; Paul, R.; Gold, R.; Tashima, K.; Flanigan, T. // Clinical Infectious Diseases;11/15/2004, Vol. 39 Issue 10, p1545 

    Presents a letter to the editor about treating HIV encephalopathy with antiretroviral therapy.

  • Tamiflu 'cure' is an excuse for careless spread. Newgrosh, Bernard // Pulse;8/19/2009, Vol. 69 Issue 26, p17 

    A letter to the editor is presented about using antiviral drugs to limit the spread of infection.

  • Reply to Collins et al. and to Singh. Mandell, Lionel A.; Wunderink, Richard G.; Anzueto, Antonio; Bartlett, John G.; Campbell, G. Douglas; Dean, Nathan C.; Dowell, Scott F.; File Jr., Thomas M.; Musher, Daniel M.; Niederman, Michael S.; Torres, Antonio; Whitney, Cynthia G. // Clinical Infectious Diseases;7/1/2007, Vol. 45 Issue 1, p134 

    A response by Lionel A. Mandell and colleagues to a letter to the editor about the use of antiviral medication for the treatment of influenza.

  • Combination Antiretroviral Therapy with Tenofovir, Emtricitabine or Lamivudine, and Nevirapine. Redfield, Robert R.; Morrow, J. Scott // Clinical Infectious Diseases;10/1/2008, Vol. 47 Issue 7, p984 

    A letter to the editor is presented in response to the article about regimens that consist tenofovir, emtricitabine and nevirapine associated with a risk of early virologic failure in antiretroviral-naive, which appeared in the previous issue.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics